Satisfaction with treatment for attention-deficit/hyperactivity disorder

American Journal of Managed Care

Volumn 10, Issue SUPPL. 6, 2004, Pages

  Bukstein, Oscar G ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE;

AGE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; DRUG EFFICACY; EXPECTATION; HUMAN; MANAGED CARE ORGANIZATION; PARENT; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; SYMPTOM; TEACHER; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DEMOGRAPHY; HUMANS; PATIENT SATISFACTION; TREATMENT OUTCOME; UNITED STATES;

EID: 3242749792     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Robison LM, Sclar DA, Skaer TL, Galin RS. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clin Pediatr. 1999;38:209-217.
2. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996;98:1084-1088.
3. Zito JM, Safer DJ, dosReis S, Magoler LS, Gardner JF, Zarin DA. Psychotherapeutic medication patterns for youths with attention-deficit/ hyperactivity disorder. Arch Pediatr Adolesc Med. 1999;153:1257-1263.
4. American Academy of Pediatrics Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108:1033-1044.
5. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(suppl 10):85S-121S.
6. Greenhill LL, Pliszka S, Dulcan MK, et al. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2001;40:1352-1355.
7. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56:1073-1086.
8. Aharony L, Strasser S. Patient satisfaction: what we know about and what we still need to explore. Med Care Rev. 1993;50:49-79.
9. Bilbrey J, Bilbrey P. Judging, trusting, and utilizing outcomes data: a survey of behavioral health care payers. Behav Health Care Tomorrow. 1995:62-65.
10. Bickman L. Are you satisfied with satisfaction? Ment Health Serv Res. 2000;2:125.
11. Daniels A, Kramer TL, Mahesh NM. Quality indicators measured by behavioral group practices. Behav Health Care Tomorrow. 1995;55-56.
12. Kazdin AE, Wassell G. Barriers to treatment participation and therapeutic change among children referred for conduct disorder. J Clin Child Psychol. 1999;28:160-172.
13. Hengeller SW, Pickrel SG, Brondino MJ, Crouch JL. Eliminating (almost) treatment dropout of substance abusing or dependent delinquents through home-based multisystemic therapy. Am J Psychiatry. 1996;153:427-428.
14. Pekarik G. Relationship of clients' reasons for dropping out of treatment to outcome and satisfaction. J Clin Psychol. 1992;48:91-98.
15. Wierzbicki M, Pekarik G. A meta-analysis of psychotherapy dropout. Prof Psychol Res Prac. 1993;23:190-195.
16. Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs. 2003;17:117-131.
17. Deane FP. Client satisfaction with psychotherapy in two outpatient clinics in New Zealand. Eval Prog Plan. 1993;16:87-94.
18. Efron D, Jarman FC, Barker MJ. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder. J Paediatr Child Health. 1998;34:288-292.
19. Marple RL, Kroenke K, Lucey CR, Wilder J, Lucas CA. Concerns and expectations in patients presenting with physical symptoms, frequency, physician perceptions and actions, and 2-week outcome. Arch Intern Med. 1997;157:1482-1488.
20. Pelham WE, Gnagy EM, Greiner AR, MTA Cooperative Group. Parent and teacher satisfaction with treatment and evaluation of effectiveness. Poster presented at: Annual Meeting of the Association for the Advancement of Behavior Therapy; November 2000; New Orleans, La.
21. Bussing R, Schoenberg NE, Perwien AR. Knowledge and information about ADHD: evidence of cultural differences among African-American and white parents. Soc Scien Med. 1998;46:919-928.
22. Hoagwood K, Kelleher KJ, Feil M, Comer DM. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry. 2000;39:198-206.
23. Bauermeister JJ, Canino G, Bravo M, et al. Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children. J Am Acad Child Adolesc Psychiatry. 2003;42:851-855.
24. Gingerich KJ, Turnock P, Litfin JK, Rosen LA. Diversity and attention deficit hyperactivity disorder. J Clin Psychol. 1998;54:415-426.
25. Dosreis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2003;24:155-162.
26. Arnold LE, Elliott M, Sachs L, et al. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol. 2003;71:713-727.
27. Rouse LW, MacCabe N, Toprac MG. Measuring satisfaction with community-based services for severely emotionally disturbed children: a comparison of questionnaires for children and parents. Paper presented at: the annual conference, A System of Care for Children's Mental Health: Expanding the Research Base; March 1994; Tampa, Fla.
28. Shapiro JP, Welker CJ, Jacobson BJ. The youth client satisfaction questionnaire: development, construct validation, and factor structure. J Child Clin Psychol. 1997;26:87-98.
29. Lambert W, Salzer MS, Bickman L. Clinical outcome, consumer satisfaction, and ad hoc ratings of improvement in children's mental health. J Consult Clin Psychol. 1998;66:270-279.
30. Eisen SV. Client satisfaction and clinical outcomes - do we need to measure both? Behav Health Tomorrow. 1996;5:71-73.
31. Weiss B, Catron T, Harris V, Phung TM. The effectiveness of traditional child psychotherapy. J Consult Clin Psychol. 1999;67:82-94.
32. Ankuta GY, Abeles N. Client satisfaction, clinical significance, and meaningful change in psychotherapy. Professional Psychol Res Practice. 1993;24:70-74.
33. Hermann RC, Ettner SL, Dorwart RA. The influence of psychiatric disorders on patients' ratings of satisfaction with health care. Med Care. 1998;36:720-727.
34. Cleary PD, Edgman-Levitan S, Roberts M, et al. Patients evaluate their hospital care: a national survey. Health Aff. 1991;10:254-267.
35. Bussing R, Gary FA. Practice guidelines and parental ADHD treatment evaluations: friends or foes. Harv Rev Psychiatry. 2001;9:223-233.
36. Garland AF, Aarons GA, Saltzman MD, Kruse MI. Correlates of adolescents' satisfaction with mental health services. Ment Health Serv Res. 2000;2:127-139.
37. Rosen LD, Heckman MA, Carro MG, Burchard JD. Satisfaction, involvement, and unconditional care: the perceptions of children and adolescents receiving wraparound services. J Child Fam Stud. 1994;3:55-67.
38. Wolf MM. Social validity: the case for subjective measurement or how applied behavior analysis is finding its heart. J Applied Behavior Analysis. 1978;11:203-214.
39. Kazdin AE. Assessing the clinical or applied importance of behavior change through social validation. Behavior Modification. 1977;1:427-452.
40. Foster SL, Mash EJ. Assessing social validity in clinical treatment research: issues and procedures. J Consult Clin Psychol. 1999;67:308-319.
41. Corkum P, Rimer P, Schachar R. Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: impact on enrollment and adherence to a 12-month treatment trial. Can J Psychiatry. 1999;44:1043-1048.
42. Bennett DS, Power TJ, Rostain AL, Carr DE. Parent acceptability and feasibility of ADHD interventions: assessment, correlates, and predictive validity. J Pediatr Psychol. 1996;21:643-657.
43. Kazdin AE, Holland L, Crowley M. Family experience of barriers to treatment and premature termination from child therapy. J Consult Clin Psychol. 1997;65:453-463.
44. Cross-Calvert S, Johnston C. Acceptability of treatments for child behavior problems: issues and implications for future research. J Clin Child Psychol. 1990;19:61-74.
45. Liu C, Robin AL, Brenner S, Eastman J, et al. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder. Pediatrics. 1991;88:560-565.
46. Miller DL, Kelley ML. Treatment acceptability: the effects of parent gender, marital adjustment, and child behavior. Child Fam Behav Ther. 1992;14:11-23.
47. Reimers TM, Wacker DP, Cooper LI, DeRaad AO. Acceptability of behavioral treatments for children: analog and naturalistic evaluations by parents. School Psychol Rev. 1992;21:628-643.
48. Tarnowski KJ, Simonian SJ, Park A, Bekeny P. Acceptability of treatments for child behavioral disturbance: race, socioeconomic status, and multicomponent treatment effects. Child Fam Behav Ther. 1992;14:25-38.
49. Pisecco S, Huzinec C, Curtis D. The effect of child characteristics on teachers' acceptability of classroom-based behavioral strategies and psychostimulant medication for the treatment of ADHD. J Clin Child Psychol. 2001;30:413-421.
50. Power TJ, Hess LE, Bennett DS. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers. Develop Behav Pediatr. 1995;16:238-243.
51. Conners CK, Epstein JN, March, JS, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry. 2001;40:159-167.
52. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40:147-158.
53. Pelham WE, Gnagy EM, Greiner AR, et al. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol. 2000;28:507-526.
54. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40:168-179.
55. Wells KC, Epstein JN, Hinshaw SP, et al. Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol. 2000;28:543-553.
56. Jones ML, Eyberg SM, Adams CD, Boggs SR. Treatment acceptability of behavioral interventions for children: an assessment by mothers of children with disruptive behavior disorders. Child Fam Behavior Therap. 1998;20:15-26.
57. Gage JD, Wilson LJ. Acceptability of attention-deficit/hyperactivity disorder interventions: a comparison of parents. J Atten Disorder. 2000;4:174-182.
58. Gage JD. Parents' and teachers' acceptability of treatments for attention-deficit/hyperactivity disorder: the effects of presentation and information delivery. Dissertation Abstracts International: Section B: the Sciences & Engineering. 2002;63(1-B):524.
59. Rostain AL, Power TJ, Atkins MS. Assessing parents' willingness to pursue treatment for children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1993;32:175-181.
60. Duckro PN, Beal D, George C. Research on the effects of disconfirmed client role expectations in psychotherapy: a critical review. Psychol Bull. 1979;86:260-275.
61. Silverman WH, Beech RP. Are dropouts, dropouts? J Community Psychol. 1979;7:236-242.
62. Jackson JL, Chamberlin J, Kroenke K. Predictors of patient satisfaction. Soc Sci Med. 2001;52:609-620.
63. Like R, Zyzanski SJ. Patient satisfaction with the clinical encounter: social psychological determinants. Soc Sci Med. 1987;24:351-357.
64. Williams B. Patient satisfaction: a valid concept? Soc Sci Med. 1994;38:509-516.
65. Mason K, Olmos-Galla A, Baon D, McQuilken M, Henley A, Fisher S. Exploring the consumer's and provider's perspective on service quality in community mentl health care. Community Ment Health J. 2004;40:33-46.
66. Dirkson SJ, D'Imperio JM, Birdsall D, Hatch SJ. A post-marketing clinical experience study of Metadate CD. Curr Med Res Opin. 2002;18:371-380.
67. Wolraich ML, Greenhill LL, Pelham WE, et al. Randomized, controlled trial of OROS® methylphenidate once a day in children with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108:883-892.
68. Biederman J, Lopez FA, Boellner SW, et al. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002;110:258-266.
69. Wilens T, Pelham W, Stein M, et al. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003;42:424-433.
70. Aman MG, Wolford PL. Consumer satisfaction with involvement in drug research: a social validity study. J Amer Acad Child Adolesc Psychiatr. 1995;34:940-945.
71. Johnston C, Fine S. Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance. J Pediatr Psychol. 1993;18:717-730.
72. Pelham WE, Gnagy EM, Burrows-Maclean L, et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001;107:e105.
73. Wan GJ, Bukstein O. Satisfaction with once-daily OROS methylphenidate in children and adolescents with ADHD. Poster presented at: 16th US Psychiatric Mental Health Congress; November 6-9, 2003; Orlando, Fla.
74. Heil SH, Holmes HW, Bichel WK, et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend. 2002;67:149-156.
75. Sleator EK, Ullmann RK, von Neumann A. How do hyperactive children feel about taking stimulants and will they tell the doctor? Clin Pediatr. 1982;21:474-479.
76. Wigal S. Concerta: preference in children. Poster presented at: American Psychological Association; August 22-25, 2003; Chicago, Ill.